Ell-Cranell is a brand name for a topical solution primarily used in the treatment of androgenetic alopecia (hereditary hair loss). It is marketed primarily in European countries. The product's main active ingredient is alfatradiol, which works by targeting the hormonal processes involved in hair loss.
Active Ingredient
The active pharmaceutical ingredient in Ell-Cranell is
alfatradiol. Alfatradiol is a synthetic steroid hormone, specifically a 17α-estradiol derivative. Unlike other estrogens, alfatradiol exhibits minimal systemic estrogenic effects because of its specific chemical structure and metabolic pathway, which prevents its conversion into active estrogens.
Mechanism of Action
Ell-Cranell's efficacy is attributed to alfatradiol's ability to inhibit the enzyme 5α-reductase within the hair follicles and scalp. This enzyme is responsible for converting testosterone into dihydrotestosterone (DHT). DHT is a potent androgen that plays a crucial role in the miniaturization of hair follicles and eventual hair loss in individuals with genetic predisposition to androgenetic alopecia. By reducing the local concentration of DHT in the scalp, alfatradiol helps to protect hair follicles from its damaging effects, potentially slowing down hair loss and promoting the growth of stronger hair. The local application of alfatradiol aims to ensure its action is concentrated where needed, minimizing systemic absorption and potential side effects.
Indications
Ell-Cranell is indicated for the treatment of mild to moderate forms of androgenetic alopecia in both men and women. It is typically used for diffuse hair loss associated with this condition, where hair thinning occurs evenly across the scalp rather than in distinct patches.
Application
The product is applied directly to the scalp, usually once daily, using a specialized applicator. The solution is massaged into the affected areas to ensure even distribution and absorption. Consistency in application is generally recommended for several months to observe noticeable effects.
Manufacturer
Ell-Cranell is manufactured by Almirall Hermal GmbH, a German pharmaceutical company that is part of the global Almirall group.
Safety and Side Effects
Due to its local application and minimal systemic absorption, alfatradiol generally has a favorable safety profile. Common side effects, if any, are usually mild and localized to the application site, such as scalp irritation, itching, or dryness. Systemic hormonal side effects are rare because alfatradiol is not readily converted into active estrogens within the body. However, as with any medication, users are advised to consult a healthcare professional for specific guidance and to review the product's package insert.